182 related articles for article (PubMed ID: 31467038)
1. Glutamine antagonism attenuates physical and cognitive deficits in a model of MS.
Hollinger KR; Smith MD; Kirby LA; Prchalova E; Alt J; Rais R; Calabresi PA; Slusher BS
Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31467038
[TBL] [Abstract][Full Text] [Related]
2. Glutamine Antagonist JHU-083 Normalizes Aberrant Hippocampal Glutaminase Activity and Improves Cognition in APOE4 Mice.
Hollinger KR; Zhu X; Khoury ES; Thomas AG; Liaw K; Tallon C; Wu Y; Prchalova E; Kamiya A; Rojas C; Kannan S; Slusher BS
J Alzheimers Dis; 2020; 77(1):437-447. PubMed ID: 32675407
[TBL] [Abstract][Full Text] [Related]
3. Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosis.
Hollinger KR; Alt J; Riehm AM; Slusher BS; Kaplin AI
Brain Res; 2016 Mar; 1635():105-12. PubMed ID: 26826008
[TBL] [Abstract][Full Text] [Related]
4. High dose of dexamethasone protects against EAE-induced motor deficits but impairs learning/memory in C57BL/6 mice.
Dos Santos N; Novaes LS; Dragunas G; Rodrigues JR; Brandão W; Camarini R; Peron JPS; Munhoz CD
Sci Rep; 2019 Apr; 9(1):6673. PubMed ID: 31040362
[TBL] [Abstract][Full Text] [Related]
5. Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems.
Wang Y; Cao L; Xu LM; Cao FF; Peng B; Zhang X; Shen YF; Uzan G; Zhang DH
J Neuroimmune Pharmacol; 2015 Sep; 10(3):506-16. PubMed ID: 25773257
[TBL] [Abstract][Full Text] [Related]
6. Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders.
Nedelcovych MT; Kim BH; Zhu X; Lovell LE; Manning AA; Kelschenbach J; Hadas E; Chao W; Prchalová E; Dash RP; Wu Y; Alt J; Thomas AG; Rais R; Kamiya A; Volsky DJ; Slusher BS
J Neuroimmune Pharmacol; 2019 Sep; 14(3):391-400. PubMed ID: 31209775
[TBL] [Abstract][Full Text] [Related]
7. Crotoxin down-modulates pro-inflammatory cells and alleviates pain on the MOG
Teixeira NB; Sant'Anna MB; Giardini AC; Araujo LP; Fonseca LA; Basso AS; Cury Y; Picolo G
Brain Behav Immun; 2020 Feb; 84():253-268. PubMed ID: 31843645
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Khan N; Woodruff TM; Smith MT
Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Rahn KA; Watkins CC; Alt J; Rais R; Stathis M; Grishkan I; Crainiceau CM; Pomper MG; Rojas C; Pletnikov MV; Calabresi PA; Brandt J; Barker PB; Slusher BS; Kaplin AI
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20101-6. PubMed ID: 23169655
[TBL] [Abstract][Full Text] [Related]
10. Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.
Thomé R; Moraes AS; Bombeiro AL; Farias Ados S; Francelin C; da Costa TA; Di Gangi R; dos Santos LM; de Oliveira AL; Verinaud L
PLoS One; 2013; 8(6):e65913. PubMed ID: 23799062
[TBL] [Abstract][Full Text] [Related]
11. Spasticity Treatment Ameliorates the Efficacy of Melatonin Therapy in Experimental Autoimmune Encephalomyelitis (EAE) Mouse Model of Multiple Sclerosis.
Ghareghani M; Zibara K; Sadeghi H; Farhadi N
Cell Mol Neurobiol; 2018 Jul; 38(5):1145-1151. PubMed ID: 29497878
[TBL] [Abstract][Full Text] [Related]
12. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
Zhang D; Qiao L; Fu T
Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388
[TBL] [Abstract][Full Text] [Related]
13. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
[TBL] [Abstract][Full Text] [Related]
14. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.
Touil T; Ciric B; Ventura E; Shindler KS; Gran B; Rostami A
J Neurol Sci; 2008 Aug; 271(1-2):191-202. PubMed ID: 18544456
[TBL] [Abstract][Full Text] [Related]
15. Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis.
Kuo PC; Brown DA; Scofield BA; Paraiso HC; Wang PY; Yu IC; Yen JH
Brain Behav Immun; 2018 May; 70():76-87. PubMed ID: 29604346
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.
Virgili N; Espinosa-Parrilla JF; Mancera P; Pastén-Zamorano A; Gimeno-Bayon J; Rodríguez MJ; Mahy N; Pugliese M
J Neuroinflammation; 2011 Nov; 8():149. PubMed ID: 22047130
[TBL] [Abstract][Full Text] [Related]
17. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
Shen R; Deng W; Li C; Zeng G
Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476
[TBL] [Abstract][Full Text] [Related]
18. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
[TBL] [Abstract][Full Text] [Related]
19. Beneficial Effects of the Calcium Channel Blocker CTK 01512-2 in a Mouse Model of Multiple Sclerosis.
Silva RBM; Greggio S; Venturin GT; da Costa JC; Gomez MV; Campos MM
Mol Neurobiol; 2018 Dec; 55(12):9307-9327. PubMed ID: 29667130
[TBL] [Abstract][Full Text] [Related]
20. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
